🎯
LATEST VERIFIED ALGORITHMIC EXECUTION
Quantitative engine captured a net profit of +19.26% on $OC in just 23h 32m.
IVA
$IVA.PA
🔒 EuropeInventiva SA
AVG HISTORICAL GAP
-0.45%
MAX GAP RECORD
-2.30%
🔒 PRO INSTITUTIONAL
AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡
SENTINEL HISTORICAL GAP VIEWER
// $IVA.PA
📊 1-YEAR TIMELINE (GAPS PLOTTED)
🔮 SIMULATE SETUP 🔒
GAP INSPECTION // PLAYBACK PROTOCOL
$IVA.PA
HISTORICAL GAP OCCURRENCE
Analyzing price jump between T-1 close and opening auction.
EVENT DATE—
GAP MAGNITUDE—
T-1 CLOSE—
OPEN PRICE—
AI DIRECTIONPRO ONLY 🔒
Bullish Opening Gap
Bearish Opening Gap
T-1 Close Baseline
CATALYSTS & GAP HISTORY
| Sep 25, 2026 Earnings Release 2026-09-25 (AFTER CLOSE (17:00)) |
+1.41%
|
| Mar 30, 2026 Earnings Release 2026-03-30 (BEFORE OPEN) |
-2.30%
|
VOLATILITY & GAP BIAS
AVG GAP MOVE
1.9%
Bullish Gaps (1)
Bearish Gaps (1)
Neutral / Flat (0)
📖 Intelligence Summary
Inventiva SA is a clinical-stage biopharmaceutical company, which focuses on the development of oral small molecule therapies for the treatment of non-alcoholic steatohepatitis, or NASH, and other diseases with significant unmet medical need. It owns an in-house drug-discovery platform that develops internal oncology and fibrosis discovery pipeline with approaches centered…
NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗